杨凡;刘莲;曹邦伟;

• 1:首都医科大学附属北京友谊医院肿瘤中心

摘要(Abstract)：

<正>随着医学领域的不断飞速发展,恶性肿瘤的治疗手段也日益更新,包括手术、化疗、放疗、靶向治疗、免疫制剂等治疗,其中化疗仍占有极其重要的地位。然而,化疗所带来的不良反应常让患者的依从性降低,尽管患者的生存时间得到延长,但化疗相关不良反应却影响着患者的生活质量。化疗最常见的不良反应即为化疗相关恶心呕吐(chemotherapy

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(No.81272615);; 北京市“215”高层次卫生人才资助项目(No.2011-3-007)

作者(Authors): 杨凡;刘莲;曹邦伟;

DOI: 10.14009/j.issn.1672-2124.2017.08.003

参考文献(References)：

• [1]Sheikhi MA,Ebadi A,Talaeizadeh A,et al.Alternative methods to treat nausea and vomiting from cancer chemotherapy[J].Chemother Res Pract,2015:818759.doi:10.1155/2015/818759.
• [2]Ranganath P,Ebinhorn L,Albany C.Management of chemotherapy induced nausea and vomiting in patients on multiday cisplatin based combination chemotherapy[J].Biomed Res Int,2015:943618.doi:10.1155/2015/943618.
• [3]Hesketh PJ,Bohlke K,Lyman GH,et al.Antiemetics:American society of Clinical Oncology Focused Guideline Update[J].J Clin Oncol,2015,34(4):381-386.
• [4]廖世雄,刘燕好,张婕斐,等.昂丹司琼的药物相互作用[J].中国医院用药评价与分析,2014,14(3):279-281.
• [5]Schwartzberg L,Harrow B,Lal LS,et al.Resource utilization for chemotherapy—induced nausea and vomiting events in patients with solid tumors treated with antiemetic regimens[J].Am Health Drug Benefits,2015,8(5):273-282.
• [6]Aapro MS,Grunberg SM,Manikhas GM,et al.A phaseⅢ,doule-blind,randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy[J].Ann Oncol,2016,17(9):1441-1449.
• [7]Eisenberg P,Figureroa-Vadillo J,Zamora R,et al.Improved prevetion of moderately emetogenic chemotherapy-induced nausea and vomitingwith palonosetron,a pharmacologically novel 5-HT3receptor antagonist:results of a phasesⅢ,single-dose trial versus dolasetron[J].Cancer,2003,98(11):2473-2482.
• [8]Hesketh PJ,Grunberg SM,Gralla RJ,et al.The oral neurokinin-1antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting:a multinational,randomized,double-blind,placebo-controlled trial in patients receiving high-dose cisplatin—the Aprepitant Protocol 052 Study Group[J].J Clin Oncol,2003,21(22):4112-4119.
• [9]杨凡,李卉惠,赵磊,等.阿瑞匹坦联合5-HT3RA预防化疗引起呕吐的Meta分析[J].实用医学杂志,2016,32(19):3255-3259.
• [10]Rapoport BL,Chasen MR,Gridelli C,et al.Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomi-ting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer:two randomised,active-contr-olled,doubleblind,phase 3 trials[J].Lancet Oncol,2015,16(9):1079-1089.
• [11]Schwartzberg LS,Modiano MR,Rapoport BL,et al.Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer:a randomised,active-controlled,double-blind,phase 3trial[J].Lancet Oncol,2015,16(9):1071-1078.
• [12]Hesketh PJ,Rossi G,Rizzi G,et al.Efficacy and safety of NEPA,an oral combination of netupitant and palonosetron,for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy:a randomized dose-ranging pivotal study[J].Ann Oncol,2014,25(7):1340-1346.
• [13]Aapro M,Rugo H,Rossi G,et al.A randomized phaseⅢstudy evaluating the efficacy and safety of NEPA,a fixed-dose combination of netupitant and palonosetron,for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy[J].Ann Oncol,2014,25(7):1328-1333.
• [14]dos Santos LV,Souza FH,Brunetto AT,et al.Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting:a systematic review[J].J Natl Cancer Inst,2012,104(17):1280-1292.
• [15]Zhou M,Popovic M,Pasetka M,et al.Update on the management of chemotherapy-induced nausea and vomiting-focus on palonosetron[J].Ther Clin Risk Manag,2015,11:713-729.
• [16]Jordan k,Jahn F,Aapro M.Recent developments in the prevention of chemotherapy-induced nausea and vomiting(CINV):a comprehensive review[J].Ann Oncol,2015,26(6):1081-1090.
• [17]Ioannidis JP,Hesketh PJ,Lau J.Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting:a meta-analysis of randomized evidence[J].J Clin Oncol,2000,18(19):3409-3422.
• [18]Navari RM,Gray SE,Kerr AC.Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting:a randomized phaseⅢtrial[J].J Support Oncol,2011,9(5):188-195.
• [19]王玉霞,郭兴科,李圆圆,等.高良姜与生姜组合物的抗肿瘤止呕作用[J].泰山医学院学报,2016,37(7):735-737.
• [20]袁敏,胡陵静,彭莉,等.止吐膏穴位贴敷辅助治疗化疗后恶心呕吐的临床观察[J].中国药房,2015,26(23):3241-3243.
• [21]张林英,林才志,陈漫,等.加味香砂六君子汤联合5-HT3受体拮抗剂类止吐药治疗肿瘤化疗呕吐的系统评价[J].湖南中医杂志,2016,32(1):147-149,152.